by Keum Boryeong
Published 10 Nov.2020 14:46(KST)
[Asia Economy Reporter Geum Bo-ryeong] On the news of vaccine development, the leading untact stocks Naver (NAVER) and Kakao plummeted on the 10th.
As of 2:35 PM that day, Naver recorded 282,500 KRW, down 5.2% (15,500 KRW) from the previous close. At the same time, Kakao was down 4.58% (17,000 KRW) to 354,500 KRW.
With the interim results of the Phase 3 clinical trial of the novel coronavirus infection (COVID-19) vaccine jointly developed by the US pharmaceutical company Pfizer and the German BioNTech showing over 90% preventive efficacy, untact-related stocks showed a downward trend.
In the US market, the Nasdaq index, centered on technology stocks, closed at 11,713.78, down 1.53% (181.45 points) on the 9th (local time).
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.